Drug intelligence / Profile preview

aloxiprin

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Aloxiprin, also known as aluminium acetylsalicylate, is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain and inflammation associated with musculoskeletal and joint disorders. It is a chemical compound formed from aluminium hydroxide and aspirin (acetylsalicylic acid). Aloxiprin acts as an anti-inflammatory, antipyretic, analgesic, and antiplatelet agent. Its mechanism of action involves inhibition of cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) enzymes, leading to reduced synthesis of prostaglandins and thromboxanes—key mediators in inflammation and pain pathways. This results in decreased inflammation, fever reduction, pain relief, and inhibition of platelet aggregation[1][3][6][8]. Aloxiprin may be preferred over aspirin alone due to potentially improved gastrointestinal tolerability.

Brand names
Palaprin Forte
Other names
aluminium acetylsalicylatePalaprin Forte
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on aloxiprin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on aloxiprin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call